Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells

M. Zavatti, M. Guida, T. Maraldi, F. Beretti, L. Bertoni, G. B. La Sala, A. De Pol

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims Ferutinin is a diaucane sesquiterpene with a high estrogenic activity. Since ferutinin is able to enhance osteoblastic differentiation of human amniotic fluid stem cells (hAFSCs), the aim of this study was to evaluate the role of the estrogen receptors α (ERα) and G-protein coupled receptor 30 (GPR30) in ferutinin-mediated osteoblastic differentiation. Moreover, it was investigated if MEK/ERK and PI3K/Akt signaling pathways are involved in ferutinin-induced effects. Main methods hAFSCs were cultured in a standard medium or in an osteoblastic medium for 14 or 21 days and ferutinin was added at 10− 8 M. Immunofluorescence techniques and Western-blot 21analysis were used to study estrogen receptors and signaling pathways. Key findings In both undifferentiated and differentiated hAFSCs we identified ERα and GPR30 with a nuclear or cytoplasmatic localization, respectively. The presence of ferutinin in the osteoblastic medium leads to an increase in ERα expression. To dissect the role of estrogen receptors, MPP and G15 were used to selectively block ERα and GPR30, respectively. Notably, ferutinin enhanced osteoblastic differentiation in cells challenged with G15. Ferutinin was able to increase ERK and Akt phosphorylations with a different timing activation. These phosphorylations were antagonized by PD0325901, a MEK inhibitor, and wortmannin, a PI3K inhibitor. Both MPP and G15 inhibited the ferutinin-induced MEK/ERK and PI3K/Akt pathway activations. In the osteoblastic condition, PD0325901, but not wortmannin, reduced the expression of OPN and RUNX-2, whereas ferutinin abrogated the down-modulation triggered by PD0325901. Significance PI3K/Akt pathways seems to mediate the enhancement of hAFSCs osteoblastic differentiation triggered by ferutinin through ERα.

Original languageEnglish
Pages (from-to)15-22
Number of pages8
JournalLife Sciences
Volume164
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Amniotic Fluid
Stem cells
Estrogen Receptors
Stem Cells
Fluids
Phosphatidylinositol 3-Kinases
Mitogen-Activated Protein Kinase Kinases
G-Protein-Coupled Receptors
Phosphorylation
Cell Differentiation
4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en
Chemical activation
Sesquiterpenes
Fluorescent Antibody Technique
Western Blotting
Modulation

Keywords

  • Estrogen receptor signaling
  • Ferutinin
  • hAFSCs
  • Osteoblastic differentiation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells. / Zavatti, M.; Guida, M.; Maraldi, T.; Beretti, F.; Bertoni, L.; La Sala, G. B.; De Pol, A.

In: Life Sciences, Vol. 164, 01.11.2016, p. 15-22.

Research output: Contribution to journalArticle

Zavatti, M. ; Guida, M. ; Maraldi, T. ; Beretti, F. ; Bertoni, L. ; La Sala, G. B. ; De Pol, A. / Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells. In: Life Sciences. 2016 ; Vol. 164. pp. 15-22.
@article{97aba1b34866457b9c8c5fe93dbe420e,
title = "Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells",
abstract = "Aims Ferutinin is a diaucane sesquiterpene with a high estrogenic activity. Since ferutinin is able to enhance osteoblastic differentiation of human amniotic fluid stem cells (hAFSCs), the aim of this study was to evaluate the role of the estrogen receptors α (ERα) and G-protein coupled receptor 30 (GPR30) in ferutinin-mediated osteoblastic differentiation. Moreover, it was investigated if MEK/ERK and PI3K/Akt signaling pathways are involved in ferutinin-induced effects. Main methods hAFSCs were cultured in a standard medium or in an osteoblastic medium for 14 or 21 days and ferutinin was added at 10− 8 M. Immunofluorescence techniques and Western-blot 21analysis were used to study estrogen receptors and signaling pathways. Key findings In both undifferentiated and differentiated hAFSCs we identified ERα and GPR30 with a nuclear or cytoplasmatic localization, respectively. The presence of ferutinin in the osteoblastic medium leads to an increase in ERα expression. To dissect the role of estrogen receptors, MPP and G15 were used to selectively block ERα and GPR30, respectively. Notably, ferutinin enhanced osteoblastic differentiation in cells challenged with G15. Ferutinin was able to increase ERK and Akt phosphorylations with a different timing activation. These phosphorylations were antagonized by PD0325901, a MEK inhibitor, and wortmannin, a PI3K inhibitor. Both MPP and G15 inhibited the ferutinin-induced MEK/ERK and PI3K/Akt pathway activations. In the osteoblastic condition, PD0325901, but not wortmannin, reduced the expression of OPN and RUNX-2, whereas ferutinin abrogated the down-modulation triggered by PD0325901. Significance PI3K/Akt pathways seems to mediate the enhancement of hAFSCs osteoblastic differentiation triggered by ferutinin through ERα.",
keywords = "Estrogen receptor signaling, Ferutinin, hAFSCs, Osteoblastic differentiation",
author = "M. Zavatti and M. Guida and T. Maraldi and F. Beretti and L. Bertoni and {La Sala}, {G. B.} and {De Pol}, A.",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.lfs.2016.09.005",
language = "English",
volume = "164",
pages = "15--22",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells

AU - Zavatti, M.

AU - Guida, M.

AU - Maraldi, T.

AU - Beretti, F.

AU - Bertoni, L.

AU - La Sala, G. B.

AU - De Pol, A.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Aims Ferutinin is a diaucane sesquiterpene with a high estrogenic activity. Since ferutinin is able to enhance osteoblastic differentiation of human amniotic fluid stem cells (hAFSCs), the aim of this study was to evaluate the role of the estrogen receptors α (ERα) and G-protein coupled receptor 30 (GPR30) in ferutinin-mediated osteoblastic differentiation. Moreover, it was investigated if MEK/ERK and PI3K/Akt signaling pathways are involved in ferutinin-induced effects. Main methods hAFSCs were cultured in a standard medium or in an osteoblastic medium for 14 or 21 days and ferutinin was added at 10− 8 M. Immunofluorescence techniques and Western-blot 21analysis were used to study estrogen receptors and signaling pathways. Key findings In both undifferentiated and differentiated hAFSCs we identified ERα and GPR30 with a nuclear or cytoplasmatic localization, respectively. The presence of ferutinin in the osteoblastic medium leads to an increase in ERα expression. To dissect the role of estrogen receptors, MPP and G15 were used to selectively block ERα and GPR30, respectively. Notably, ferutinin enhanced osteoblastic differentiation in cells challenged with G15. Ferutinin was able to increase ERK and Akt phosphorylations with a different timing activation. These phosphorylations were antagonized by PD0325901, a MEK inhibitor, and wortmannin, a PI3K inhibitor. Both MPP and G15 inhibited the ferutinin-induced MEK/ERK and PI3K/Akt pathway activations. In the osteoblastic condition, PD0325901, but not wortmannin, reduced the expression of OPN and RUNX-2, whereas ferutinin abrogated the down-modulation triggered by PD0325901. Significance PI3K/Akt pathways seems to mediate the enhancement of hAFSCs osteoblastic differentiation triggered by ferutinin through ERα.

AB - Aims Ferutinin is a diaucane sesquiterpene with a high estrogenic activity. Since ferutinin is able to enhance osteoblastic differentiation of human amniotic fluid stem cells (hAFSCs), the aim of this study was to evaluate the role of the estrogen receptors α (ERα) and G-protein coupled receptor 30 (GPR30) in ferutinin-mediated osteoblastic differentiation. Moreover, it was investigated if MEK/ERK and PI3K/Akt signaling pathways are involved in ferutinin-induced effects. Main methods hAFSCs were cultured in a standard medium or in an osteoblastic medium for 14 or 21 days and ferutinin was added at 10− 8 M. Immunofluorescence techniques and Western-blot 21analysis were used to study estrogen receptors and signaling pathways. Key findings In both undifferentiated and differentiated hAFSCs we identified ERα and GPR30 with a nuclear or cytoplasmatic localization, respectively. The presence of ferutinin in the osteoblastic medium leads to an increase in ERα expression. To dissect the role of estrogen receptors, MPP and G15 were used to selectively block ERα and GPR30, respectively. Notably, ferutinin enhanced osteoblastic differentiation in cells challenged with G15. Ferutinin was able to increase ERK and Akt phosphorylations with a different timing activation. These phosphorylations were antagonized by PD0325901, a MEK inhibitor, and wortmannin, a PI3K inhibitor. Both MPP and G15 inhibited the ferutinin-induced MEK/ERK and PI3K/Akt pathway activations. In the osteoblastic condition, PD0325901, but not wortmannin, reduced the expression of OPN and RUNX-2, whereas ferutinin abrogated the down-modulation triggered by PD0325901. Significance PI3K/Akt pathways seems to mediate the enhancement of hAFSCs osteoblastic differentiation triggered by ferutinin through ERα.

KW - Estrogen receptor signaling

KW - Ferutinin

KW - hAFSCs

KW - Osteoblastic differentiation

UR - http://www.scopus.com/inward/record.url?scp=84988432317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988432317&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2016.09.005

DO - 10.1016/j.lfs.2016.09.005

M3 - Article

AN - SCOPUS:84988432317

VL - 164

SP - 15

EP - 22

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

ER -